Page 166 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 166
Liver Tumours: Experimental (Cont.)
YI P0265 IGF2 IS AN ONCOGENIC DRIVER IN HCC AND EMERGES AS
A POTENTIAL TARGET FOR THERAPIES
Iris Martínez-Quetglas*, Roser Pinyol, Daniel Dauch, Anna Portela,
Judit Peix, Mónica Higuera, Jessica Zucman-Rossi, Manel Esteller,
Vincenzo Mazzaferro, Lars Zender, Josep M. Llovet, Spain
YI P0266 ADENO-ASSOCIATED VIRUS 2 (AAV2) INDUCES
RECURRENT INSERTIONAL MUTAGENESIS IN HUMAN
HEPATOCELLULAR CARCINOMAS
Jean Charles Nault*, Shalini Datta, Andrea Franconi, Sandrine Imbeaud,
Maxime Mallet, Gabrielle Couchy, Eric Letouzé, Camilla Pilati,
Benjamin Verret, Jean Fréderic Blanc, Charles Balabaud,
Julien Calderaro, Alexis Laurent, Mélanie Lextexier, Paulette Bioulac-
Sage, Fabien Calvo, Jessica Zucman-Rossi, France
YI P0267 RAS AND P-ERK IN METABOLIC SYNDROME ASSOCIATED
HEPATOCELLULAR CARCINOMA (HCC)
ePOSTERS Anna Whitehead, Laura Ogle*, Gillian L. Patman, Ghazanfar Anwar,
Dina G. Tiniakos, Quentin M. Anstee, Helen L. Reeves,
The United Kingdom
YI P0268 ACCUMULATION OF DELETERIOUS PASSENGER
MUTATIONS DURING LIVER INJURY PROGRESSION TO
HEPATOCELLULAR CARCINOMA
Magdalena Budzinska*, Fabio Luciani, Nicholas Shackel, Thomas Tu,
Australia
YI P0269 THE INSULINE-LIKE GROWTH FACTOR 2 (IGF2) MRNA
BINDING PROTEIN (IMP) P62 PROMOTES CIRRHOSIS-
LINKED HEPATOCARCINOGENESIS
Sonja M. Kessler*, Beate Czepukojc, Katharina Engel, Noemi Van Hul,
Johannes Haybaeck, Isabelle Leclercq, Alexandra K. Kiemer, Germany
YI P0270 SERPINB3 AND YAP INTERPLAY INCREASE MYC
ONCOGENIC ACTIVITY
Cristian Turato*, Stefania Cannito, Davide Simonato,
Villano Gianmarco, Liliana Terrin, Santina Quarta, Alessandra Biasiolo,
Mariagrazia Ruvoletto, Silvano Fasolato, Giacomo Zanus, Umberto Cillo,
Angelo Gatta, Maurizio Parola, Patrizia Pontisso, Italy
166 The International Liver Congress™ 2015 • ILC Programme
YI P0265 IGF2 IS AN ONCOGENIC DRIVER IN HCC AND EMERGES AS
A POTENTIAL TARGET FOR THERAPIES
Iris Martínez-Quetglas*, Roser Pinyol, Daniel Dauch, Anna Portela,
Judit Peix, Mónica Higuera, Jessica Zucman-Rossi, Manel Esteller,
Vincenzo Mazzaferro, Lars Zender, Josep M. Llovet, Spain
YI P0266 ADENO-ASSOCIATED VIRUS 2 (AAV2) INDUCES
RECURRENT INSERTIONAL MUTAGENESIS IN HUMAN
HEPATOCELLULAR CARCINOMAS
Jean Charles Nault*, Shalini Datta, Andrea Franconi, Sandrine Imbeaud,
Maxime Mallet, Gabrielle Couchy, Eric Letouzé, Camilla Pilati,
Benjamin Verret, Jean Fréderic Blanc, Charles Balabaud,
Julien Calderaro, Alexis Laurent, Mélanie Lextexier, Paulette Bioulac-
Sage, Fabien Calvo, Jessica Zucman-Rossi, France
YI P0267 RAS AND P-ERK IN METABOLIC SYNDROME ASSOCIATED
HEPATOCELLULAR CARCINOMA (HCC)
ePOSTERS Anna Whitehead, Laura Ogle*, Gillian L. Patman, Ghazanfar Anwar,
Dina G. Tiniakos, Quentin M. Anstee, Helen L. Reeves,
The United Kingdom
YI P0268 ACCUMULATION OF DELETERIOUS PASSENGER
MUTATIONS DURING LIVER INJURY PROGRESSION TO
HEPATOCELLULAR CARCINOMA
Magdalena Budzinska*, Fabio Luciani, Nicholas Shackel, Thomas Tu,
Australia
YI P0269 THE INSULINE-LIKE GROWTH FACTOR 2 (IGF2) MRNA
BINDING PROTEIN (IMP) P62 PROMOTES CIRRHOSIS-
LINKED HEPATOCARCINOGENESIS
Sonja M. Kessler*, Beate Czepukojc, Katharina Engel, Noemi Van Hul,
Johannes Haybaeck, Isabelle Leclercq, Alexandra K. Kiemer, Germany
YI P0270 SERPINB3 AND YAP INTERPLAY INCREASE MYC
ONCOGENIC ACTIVITY
Cristian Turato*, Stefania Cannito, Davide Simonato,
Villano Gianmarco, Liliana Terrin, Santina Quarta, Alessandra Biasiolo,
Mariagrazia Ruvoletto, Silvano Fasolato, Giacomo Zanus, Umberto Cillo,
Angelo Gatta, Maurizio Parola, Patrizia Pontisso, Italy
166 The International Liver Congress™ 2015 • ILC Programme
